BioSpace News Archive

Merck’s KEYTRUDA ® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone in Patients With HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Regardless of PD-L1 Expression.

Artera , announced new data today at ASCO GU 2023 demonstrating that its multimodal artificial intelligence (MMAI) prognostic biomarker can help bring more personalized treatment to men with localized prostate cancer.

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.48 per share.

Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it will be attending the 2nd GPCR-Targeted Drug Discovery Summit in Boston from February 21st-23rd.

Medical device and technology company Lazurite announced that Laith Jazrawi, M.D. and Mark Schickendantz, M.D. have joined the company’s medical advisory board.

C2N Diagnostics, LLC, a leader in advanced brain health diagnostics, announced it has received a $15 million program-related investment from GHR Foundation.

Burnout and exhaustion is a growing problem across the healthcare industry.

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, plans to report fourth quarter and full year 2022 financial results and corporate highlights after the close of market on Thursday, February 23, 2023.

Singular Genomics Systems, Inc. announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, March 2, 2023.

Celldex Therapeutics, Inc. announced that it has appointed Rita Jain, M.D. to the Company’s Board of Directors.